Catalyst Wire Dossier Catalyst Wire Dossier

Yangxin Shengmai Granules

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Yangxin Shengmai Granules, covering 2020-11-13 to 2020-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Yangxin Shengmai Granules for the Treatment of Stable Angina Pectoris [Phase 4]

See pricing